Related Experiment Video
Updated: Jan 8, 2026

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
Published on: February 23, 2014
Community-acquired Pneumonia Caused by Chryseobacterium gleum in an Immunocompetent Patient
Cristian Amaral De Sousa1, Lara Bravo Quiroga1, Darwin Feliz1
1Hospital Universitario Príncipe de Asturias, Alcalá de Henares, Madrid, Spain.
Abstract:
We report the first documented case of community-acquired pneumonia caused by Chryseobacterium gleum in an immunocompetent patient without typical risk factors. This gram-negative bacillus, historically associated with nosocomial infections in immunocompromised individuals, was identified as the etiological agent in a 73-year-old woman with respiratory sepsis. The ineffectiveness of the initial empirical treatment underscored the urgent need for precise microbiological identification. A sputum culture proved to be a crucial step, as it led to the isolation of C. gleum and revealed its resistance to several commonly used antibiotics. Guided by these findings, targeted therapy with levofloxacin proved successful, leading to the patient's complete recovery. This case demonstrates that C. gleum can be a primary pathogen in healthy individuals, underscoring the fundamental importance of obtaining microbiological cultures to guide appropriate treatment and achieve a favorable outcome, especially in infections caused by rare pathogens with intrinsic resistance profiles.
More Related Videos
09:17A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii
Published on: January 2, 2017
03:22Author Spotlight: Advancing Pathogen Detection and Disease Assessment in Real-Time Using M-ROSE
Published on: March 1, 2024
Related Concept Videos
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia III: Complications and Assessment
Bacterial Phylum Chlamydiae
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Pneumonia II: Pathophysiology
Acute Pyelonephritis I: Introduction